CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 63 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $265,000 | -13.4% | 125,946 | +18.9% | 0.00% | – |
| Q1 2021 | $306,000 | -77.1% | 105,884 | -83.1% | 0.00% | – |
| Q4 2020 | $1,337,000 | +11041.7% | 624,813 | +32612.7% | 0.00% | – |
| Q3 2020 | $12,000 | -81.8% | 1,910 | -81.3% | 0.00% | – |
| Q2 2020 | $66,000 | +73.7% | 10,216 | +58.6% | 0.00% | – |
| Q4 2019 | $38,000 | +81.0% | 6,442 | +68.1% | 0.00% | – |
| Q3 2019 | $21,000 | – | 3,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |